Biogen's Felzartamab Study Targets Immunoglobulin A Nephropathy in Adults
A clinical trial is underway to evaluate the effects of felzartamab on proteinuria in adults with IgAN.
Therapeutic Area
Therapeutic area intelligence for Immunoglobulin A Nephropathy with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.